These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10787261)

  • 21. The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up.
    Trimble EL
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S1-3. PubMed ID: 7835792
    [No Abstract]   [Full Text] [Related]  

  • 22. Ovarian cancer screening: still waiting for the right answer.
    Ellwood D
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):447. PubMed ID: 19780722
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests.
    Black WC
    J Clin Oncol; 2006 Jul; 24(20):3252-60. PubMed ID: 16829649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Population screening for breast cancer: between euphoria and scepticism].
    Bossuyt PM
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1020-3. PubMed ID: 12073501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost effectiveness of universal diabetes screening.
    Manag Care Interface; 2004 Oct; 17(10):59-60. PubMed ID: 15535080
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of screening for HIV.
    Thrasher AD; Ford CL; Nearing KA
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15906435
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cancer screening: when and how?].
    Leupin N; Bauer J; Lüthi F; Liénard D; Vulliémoz D; Leyvraz S
    Rev Med Suisse; 2005 May; 1(20):1328-30, 1333-4. PubMed ID: 15991624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of screening for bowel cancer.
    Goulston K; Dent O
    Aust Health Rev; 1982 May; 5(2):15-7. PubMed ID: 10309733
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma screening: focusing the public health journey.
    Koh HK
    Arch Dermatol; 2007 Jan; 143(1):101-3. PubMed ID: 17224549
    [No Abstract]   [Full Text] [Related]  

  • 34. Routine screening of children returning home from the tropics. Authors do not prove case for routine screening.
    Okereke E; Gelletlie R
    BMJ; 1999 Jul; 319(7202):121-2. PubMed ID: 10465592
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the prevention of ovarian neoplasms].
    Shemtova SL
    Vopr Onkol; 1966; 12(3):87-8. PubMed ID: 5991969
    [No Abstract]   [Full Text] [Related]  

  • 36. It's not as simple as taking a blood test.
    Rubin R
    US News World Rep; 1994 Aug; 117(7):61. PubMed ID: 10136523
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening people with a family history of cancer. Benefit of screening for ovarian cancer is unproved.
    Bell R; Petticrew M
    BMJ; 1997 Nov; 315(7118):1306. PubMed ID: 9390065
    [No Abstract]   [Full Text] [Related]  

  • 38. Cholesterol screening and management guidelines. Policy based on Sheffield table fully satisfies authors' criteria.
    Ramsay LE; Wallis EJ; Haq IU; Jackson PR; Yeo WW
    BMJ; 1999 Apr; 318(7191):1140-1. PubMed ID: 10366266
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and laboratory directions for ovarian cancer research.
    Bast RC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S164-7. PubMed ID: 7835802
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ovarian cancers].
    Mathevet P
    Soins; 1995 Oct; (599):12-3. PubMed ID: 8701347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.